Clinical Trials Directory

Trials / Completed

CompletedNCT06880120

Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease

Improvement of Diagnostic Accuracy of Seismocardiography and Gyrocardiography for Non-Invasive Coronary Artery Disease Diagnosis: A Comparison With Coronary Artery Calcium Computed Tomography, Coronary Computed Tomography Angiography, and Invasive Coronary Angiography

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,534 (actual)
Sponsor
Heart Force Medical Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate a new, non-invasive method for detecting coronary artery disease (CAD) using seismocardiography (SCG) and gyrocardiography (GCG). These techniques measure small vibrations on the chest caused by the heartbeat using highly sensitive sensors. The goal is to determine whether this method, using the CardioClin device, can accurately detect CAD compared to standard tests like coronary calcium scans (CAC-CT), CT angiography (CCTA), and invasive coronary angiography (ICA). Patients who are already scheduled for one of these standard tests will also undergo SCG/GCG testing. The study will compare results to see if the new method provides a reliable, cost-effective, and radiation-free alternative for diagnosing CAD. This research could help improve early detection of heart disease without the need for invasive procedures.

Conditions

Interventions

TypeNameDescription
DEVICESeismocardiography (SCG) and Gyrocardiography (GCG) Diagnostic TestingThis intervention involves the use of Seismocardiography (SCG) and Gyrocardiography (GCG) Diagnostic Testing, a non-invasive technique that records mechanical vibrations of the chest caused by heart activity using high-precision accelerometers and gyroscopes. Unlike traditional imaging techniques such as coronary artery calcium computed tomography (CAC-CT), coronary computed tomography angiography (CCTA), and invasive coronary angiography (ICA), this method does not require radiation exposure (unlike CAC-CT and CCTA), is completely non-invasive and does not require contrast agents (unlike ICA), and provides real-time cardiac mechanical activity measurements rather than anatomical imaging.

Timeline

Start date
2021-05-19
Primary completion
2021-10-19
Completion
2021-11-28
First posted
2025-03-17
Last updated
2025-03-17

Locations

1 site across 1 country: Uzbekistan

Source: ClinicalTrials.gov record NCT06880120. Inclusion in this directory is not an endorsement.